{"url_path":"/sec/sgmo/10-k/2026/item-1b","section_key":"item-1b","section_title":"Item 1B UNRESOLVED STAFF COMMENTS","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-03-30","source_url":"https://www.sec.gov/Archives/edgar/data/1001233/0001628280-26-022029-index.html","accession_number":"0001628280-26-022029","cik":"0001001233","ticker":"SGMO","issuer_name":"SANGAMO THERAPEUTICS, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1001233/0001628280-26-022029-index.html","primary_entity_key":"0001001233","primary_entity_name":"SANGAMO THERAPEUTICS, INC"},"word_count":7,"has_tables":true,"body_markdown":"ITEM 1B – UNRESOLVED STAFF COMMENTS\n\nNone."}